Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib

References

• Kim HJ, Kim KH. Increased incidence of chronic actinic dermatitis in relation to climate changes and air pollution during the past 15 years in Korea. Photodermatol Photoimmunol Photomed. 2018;34(6):387–392. doi:10.1111/phpp.12402
   PubMed Web of Science ®Google Scholar
• Burfield L, Rutter KJ, Thompson B, Marjanovic EJ, Neale RE, Rhodes LE. Systematic review of the prevalence and incidence of the photodermatoses with meta-analysis of the prevalence of polymorphic light eruption. J Eur Acad Dermatol Venereol. 2023;37(3):511–520. doi:10.1111/jdv.18772
   PubMed Web of Science ®Google Scholar
• Lin N, Huang X, Ma C, Han J. Clinical and pathological findings of chronic actinic dermatitis. Photodermatol Photoimmunol Photomed. 2021;37(4):313–320. doi:10.1111/phpp.12654
   PubMed Web of Science ®Google Scholar
• Wang CX, Belsito DV. Chronic Actinic Dermatitis Revisited. Dermatitis. 2020;31(1):68–74. doi:10.1097/DER.0000000000000531
   PubMed Web of Science ®Google Scholar
• Chen Q, Tang Y, Deng H, et al. Curcumin Improves Keratinocyte Proliferation, Inflammation, and Oxidative Stress through Mediating the SPAG5/FOXM1 Axis in an In Vitro Model of Actinic Dermatitis by Ultraviolet. Dis. Markers. 2022;2022:5085183. doi:10.1155/2022/5085183
   PubMed Web of Science ®Google Scholar
• Paracha MM, Zahoor H, Khan AQ, Noor SM, Sagheer F. Efficacy Of Methotrexate Versus Azathioprine In The Treatment Of Chronic Actinic Dermatitis: a Randomized Control Trial. J Ayub Med College Abbottabad. 2022;34(Suppl 1):S644–s8. doi:10.55519/JAMC-03-S1-9643
   Google Scholar
• Vesely MD, Imaeda S, King BA. Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis. JAAD case reports. 2017;3(1):4–6. doi:10.1016/j.jdcr.2016.09.008
   PubMedGoogle Scholar
• Tu Y, Wu W, Guo Y, et al. Upregulation of hsa-miR-31-3p induced by ultraviolet affects keratinocytes permeability barrier by targeting CLDN1. Biochem. Biophys. Res. Commun. 2020;532(4):626–632. doi:10.1016/j.bbrc.2020.06.113
   PubMed Web of Science ®Google Scholar
• Bourgaux M, Marcaillou M, Matei I, et al. Man of stone: a case of a chronic actinic dermatitis mimicking a cutis verticis gyrata. J Eur Acad Dermatol Venereol. 2020;34(3):e129–e30. doi:10.1111/jdv.16068
   PubMed Web of Science ®Google Scholar
• Ali K, Wu L, Lou H, et al. Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: a Case Series. Front Med. 2022;9:803692. doi:10.3389/fmed.2022.803692
   PubMed Web of Science ®Google Scholar
• Wang T, Gong Y, Rong W, Li L, Zhang J, Li HZ. Ultraviolet A rush hardening for chronic actinic dermatitis: pilot treatment outcomes. J Dermatol. 2021;48(3):385–388. doi:10.1111/1346-8138.15667
   PubMed Web of Science ®Google Scholar
• Gu Q, Zhang Z, Yang J, et al. Chronic actinic dermatitis: a 5-year clinical analysis of 488 patients in China. Photodermatol Photoimmunol Photomed. 2023;39(3):263–268. doi:10.1111/phpp.12835
   PubMed Web of Science ®Google Scholar
• Maghfour J, Mohney L, Lim HW, Mohammad TF. Demographics and clinical presentations of 844 patients with light and dark skin types with polymorphous light eruption and chronic actinic dermatitis evaluated over 23 years. Photodermatol Photoimmunol Photomed. 2023;39(2):93–99. doi:10.1111/phpp.12863
   PubMed Web of Science ®Google Scholar
• Lee CN, Chen TY, Wong TW. The Immunogenetics of Photodermatoses. Adv Exp Med Biol. 2022;1367:369–381.
   PubMedGoogle Scholar
• Jiang AJ, Lim HW. Phototherapy in the Evaluation and Management of Photodermatoses. Dermatologic Clinics. 2020;38(1):71–77. doi:10.1016/j.det.2019.08.007
   PubMed Web of Science ®Google Scholar
• Chen JC, Lian CH. Chronic actinic dermatitis in an old adult significantly improved by dupilumab. Photodermatol Photoimmunol Photomed. 2022;38(2):176–177. doi:10.1111/phpp.12731
   PubMed Web of Science ®Google Scholar
• Patel N, Konda S, Lim HW. Dupilumab for the treatment of chronic actinic dermatitis. Photodermatol Photoimmunol Photomed. 2020;36(5):398–400. doi:10.1111/phpp.12566
   PubMed Web of Science ®Google Scholar
• Lahouel M, Ben Kahla M, Aounallah A, et al. Severe chronic actinic dermatitis treated successfully with Thalidomide. Photodermatol Photoimmunol Photomed. 2020;36(6):493–495. doi:10.1111/phpp.12588
   PubMed Web of Science ®Google Scholar
• Duraisamy P, Jagadeesan S, Thomas J. Tofacitinib in the treatment of refractory eczemas - a case series. J Dermatological Treatment. 2022;33(6):2873–2875. doi:10.1080/09546634.2022.2082355
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim HJ, Yoo DW, et al. A postulated model for photo immunopathogenesis of chronic actinic dermatitis around adaptive immunity, including Th17 cells, Tregs, TRMs, cytotoxic T cells, and/or common-γ chain receptor+ cells. Photodermatol Photoimmunol Photomed. 2023;39(2):147–154. doi:10.1111/phpp.12848
   PubMed Web of Science ®Google Scholar
• Dev A, Bishnoi A, Narang T, Vinay K. Recalcitrant chronic actinic dermatitis responding to tofacitinib: a case report. Indian J Dermatol Venereol Leprol. 2023;89(4):600–602. doi:10.25259/IJDVL_744_2022
   PubMed Web of Science ®Google Scholar
• Wang Y-J, Hui H-Z, Cheng J-R, Mao H, Diao Q-C, Shi B-J. Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment. Am j Therapeutics. 2023;30(6):e547–e548. doi:10.1097/MJT.0000000000001616
   PubMed Web of Science ®Google Scholar
• Pappa G, Sgouros D, Kanelleas A, Koumaki D, Bozi E, Katoulis A. JAK-ing up chronic actinic dermatitis with upadacitinib. Clin Exp Dermatol. 2023.
   Web of Science ®Google Scholar
• Maguire J, Gleeson D, Corso R, Pink A, Smith C, Ferguson J. Remission of chronic actinic dermatitis on baricitinib: a case report. Skin Health Dis. 2023;3(6):e243. doi:10.1002/ski2.243
   PubMedGoogle Scholar
• Jin X, Qiao J. Effectiveness of Abrocitinib in a Patient With Chronic Actinic Dermatitis. Am j Therapeutics. 2023. doi:10.1097/MJT.0000000000001671
   PubMedGoogle Scholar
• Kaushik A, Narang T, Handa S. Successful use of apremilast as a steroid-sparing agent in chronic actinic dermatitis. Dermatologic Therapy. 2020;33(6):e13809. doi:10.1111/dth.13809
   PubMed Web of Science ®Google Scholar
• Ichihashi M, Nakamura Y, Muto M, Nishikata T, Inui T, Uto Y. A case of chronic actinic dermatitis that responded completely to treatment with oral colostrum-macrophage-activating factor (colostrum-MAF). Photodermatol Photoimmunol Photomed. 2019;35(4):290–292. doi:10.1111/phpp.12469
   PubMed Web of Science ®Google Scholar
• Nassim D, Alajmi A, Jfri A, Pehr K. Apremilast in dermatology: a review of literature. Dermatologic Therapy. 2020;33(6):e14261. doi:10.1111/dth.14261
   PubMed Web of Science ®Google Scholar
• Xu Lou I, Ali K, Chen Q. Effect of nutrition in Alzheimer’s disease: a systematic review. Front Neurosci. 2023;17:1147177. doi:10.3389/fnins.2023.1147177
   PubMedGoogle Scholar
• Xu Lou I, Gil-García E, Cáceres-Matos R, Ali K, Molina E. Nutritional aspects in chronic non-cancer pain: a systematic review. Frontiers in Nutrition. 2022;9:931090. doi:10.3389/fnut.2022.931090
   PubMed Web of Science ®Google Scholar
• Fujii S, Washio K, Masaki T. Case report of chronic actinic dermatitis accompanied by ultraviolet A photosensitivity in a Chrysanthemum farmer. J Dermatol. 2019;46(7):e229–e30. doi:10.1111/1346-8138.14818
   PubMed Web of Science ®Google Scholar
• Tu Y, Wang L, Wang X, et al. LncRNA-WAKMAR2 regulates expression of CLDN1 to affect skin barrier through recruiting c-Fos. Contact Dermatitis. 2023;88(3):188–200. doi:10.1111/cod.14256
   PubMedGoogle Scholar